查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945139

全球病患自控镇痛帮浦市场（按产品类型、技术、应用和最终用户划分）预测（2026-2032年）

Patient-controlled Analgesic Pumps Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年，病患自控镇痛帮浦市场价值为5.4521亿美元，预计2026年将成长至5.8633亿美元，年复合成长率为7.09%，到2032年将达到8.8084亿美元。

关键市场统计数据
基准年 2025 5.4521亿美元
预计年份：2026年 5.8633亿美元
预测年份 2032 8.8084亿美元
复合年增长率 (%) 7.09%

针对病患自控镇痛帮浦的综合背景架构：重点在于临床需求、不断变化的医疗环境以及推动设备普及的相关人员期望

患者自控式镇痛帮浦已成为现代疼痛管理的重要工具，它将患者自主权与临床医生的监督相结合，在急性和慢性疼痛治疗​​中提供精准的镇痛方案。这些系统的发展源于临床需求，旨在提高镇痛的精准度，减少阿片类药物相关的不利事件，并支持早期活动和出院。过去十年，临床团队越来越重视那些能够实现个人化给药，并透过可程式设计锁定功能、剂量限制和整合监测来确保安全性的设备。

综合审视技术、监管和医疗服务模式的变革，这些变革正在重新定义疼痛管理领域医疗设备的预期和采购标准。

随着技术、政策和医疗服务模式的融合，患者自控镇痛泵（PCAPP）的格局正在经历快速变革，临床医生和患者对镇痛系统的期望也随之改变。连接性和嵌入式智慧技术的进步，使PCAPP从孤立的仪器发展成为更广泛的数位医疗生态系统的组成部分，从而实现即时遥测、剂量审核和远端警报，以支援更严格的临床监管。同时，阿片类药物倡议的兴起和安全性审查的加强，正在加速诸如大剂量投药频率限制、强制警报和支持机构遵守通讯协定等功能的应用。

2025年关税对美国疼痛帮浦供应链的采购、采购策略和製造选择的影响

2025年美国关税的累积影响，为医疗设备製造商和医疗系统的采购、製造和供应链管理等各个环节带来了新的动态。进口零件和成品关税的征收，使得泵浦和耗材的总到岸成本更加受到关注，促使许多製造商和经销商重新评估筹资策略。为此，各机构正在加快供应商多元化、将关键製造环节外包以及重新谈判长期供应商合约的步伐，以降低对单一供应来源的依赖风险。

透过详细的細項分析，将产品设计、临床适应症、使用环境、给药途径以及不断发展的技术需求连结起来，制定针对性策略。

细分市场层面的趋势分析突显了产品、应用、最终用户、给药途径和技术等各个维度上的明确业务驱动因素和客户期望。产品类型分为一次性弹性体装置和定量输注装置，分别满足不同的临床和操作需求。一次性弹性体装置在特定的门诊和居家照护流程中具有一次性使用的简便性和一次性使用便捷性，而定量输注装置则提供可程式设计的精确度，更适用于复杂的住院环境。临床应用包括癌症相关疼痛、分娩和术后镇痛，每种应用都需要个人化的给药方案、监测技术和病患教育方法，这些都会影响装置的选择和照护通讯协定。

区域比较分析重点在于影响全球医疗器材普及的法规结构、医疗服务模式和製造趋势。

区域趋势受法规环境、报销结构、医疗服务模式和产业能力的影响，这些因素共同作用，影响医疗器材的采用和支持方式。在美洲，重点在于监管合规性、与电子病历的互通性以及家庭输液模式的日益普及。报销政策和一体化医疗体係是采购优先事项的关键驱动因素，而该地区的製造地和分销网络则为零部件生产的近岸外包提供了途径。

策略竞争概览：揭示产品线广度、服务和软体主导的差异化如何决定疼痛泵领域的商业领先地位

病患自控式镇痛帮浦市场的竞争格局由技术差异化、服务产品、与临床生态系的伙伴关係所决定。专注于与临床工作流程整合、提供强大的售后支援以及实现数据互通性的市场参与企业，往往更受大型医疗机构的青睐，因为这些机构希望减轻临床医生的负担并提高用药安全指标。同时，提供从简单易用的一次性泵浦到多功能可程式设计泵浦等多种产品形式的製造商，能够更好地服务于包括医院、门诊中心和居家照护机构在内的各种采购管道。

为製造商、医疗系统和支付者提供具体、实用的建议，以提高医疗设备的采用率、降低风险并创造临床价值。

产业领导者应采取一系列协作行动，使产品开发、商业策略和营运韧性与不断变化的临床需求保持一致。製造商应将互通性作为核心设计原则，并确保设备支援电子病历 (EMR) 整合和无线连接，以促进封闭回路型文件记录和远端监测。加强服务模式同样重要：投资于全面的培训、快速响应的技术支援以及完善的保固和耗材供应计划，将降低医院和居家照护机构采用这些设备的门槛。

本分析所依据的研究透过严谨的多方法研究方案检验了研究结果，该方案结合了临床访谈、监管审查、产品评估和供应链分析。

本分析所依据的研究整合了多方面的证据，以确保其严谨性和实用性。主要数据包括对急诊和门诊临床医生、生物医学工程专家、供应链负责人以及有家庭输液经验的看护者进行的结构化访谈，旨在了解他们对设备可用性、安全问题和采购因素的现场观点。次要研究则纳入了对监管申报文件、临床指南、镇痛药物给药方面的同行评审文献以及公共文件的分析，以阐明影响设备设计的法规环境和标准。

综合结论强调了客製化解决方案、互通性和相关人员之间的协作对于实现设备价值的重要性。

病患自控式镇痛帮浦在临床疗效、病患自主管理和营运效率三者之间发挥着至关重要的作用。技术进步、监管重点以及不断变化的医疗环境，都在拓展人们对这类设备功能的期望，同时也提升了互通性、服务模式和供应链韧性的重要性。从产品形态、临床应用到给药途径和最终用户环境等各个方面的详细细分，凸显了「一刀切」解决方案的局限性。针对不同环境（无论是门诊手术中心、居家照护计画或医院系统）的独特需求制定专门策略，对于持续推广应用至关重要。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的患者自控式镇痛帮浦市场

  • 一次性弹性体装置
  • 定量输液设备

9. 按技术分類的病人自控式镇痛帮浦市场

  • 弹性体装置
  • 智慧泵浦
    • 电子病历集成
    • 无线连线
  • 传统泵浦

10. 按应用分類的病患自控式镇痛帮浦市场

  • 癌症相关疼痛
  • 分娩期间
  • 术后止痛

第十一章 依最终用户分類的病患自控式止痛帮浦市场

  • 门诊手术中心
  • 居家医疗环境
  • 医院

12. 按地区分類的病患自控式镇痛帮浦市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 按组别分類的病人自控式止痛帮浦市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国患者自控镇痛帮浦市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国病患自控镇痛帮浦市场

第十六章 中国病人自控镇痛帮浦市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Ace Medical
  • Avanos Medical, Inc.
  • Becton, Dickinson and Company
  • Braun Melsungen AG
  • Eitan Medical
  • Flowonix Medical
  • Fresenius Kabi
  • Halyard Health
  • ICU Medical, Inc.
  • IntraPump Infusion Systems
  • Koninklijke Philips NV
  • Medtronic plc
  • Mindray Medical International Limited
  • Moog Inc.
  • Nipro Corporation
  • Promecon Medizintechnik GmbH
  • Smiths Medical
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-C67B9E988F42

The Patient-controlled Analgesic Pumps Market was valued at USD 545.21 million in 2025 and is projected to grow to USD 586.33 million in 2026, with a CAGR of 7.09%, reaching USD 880.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 545.21 million
Estimated Year [2026] USD 586.33 million
Forecast Year [2032] USD 880.84 million
CAGR (%) 7.09%

Comprehensive contextual framing of patient-controlled analgesic pumps highlighting clinical imperatives, care setting shifts, and stakeholder expectations driving device adoption

Patient-controlled analgesic pumps have become an essential tool in contemporary pain management, bridging patient autonomy and clinician oversight to deliver targeted analgesia across acute and chronic care settings. The evolution of these systems has been driven by clinical imperatives to improve analgesic precision, reduce opioid-related adverse events, and support early mobilization and discharge pathways. Over the past decade, clinical teams have increasingly prioritized devices that enable individualized dosing while preserving safety through programmable lockouts, dose limits, and integrated monitoring.

As care shifts beyond the inpatient ward, pumps are now fundamental to ambulatory surgical centers, home infusion programs, and labor and delivery suites, creating new demands for portability, ease of use, and interoperability. Stakeholders from procurement leaders to bedside nurses and biomedical engineers seek solutions that balance operational reliability with streamlined training and clear documentation. Consequently, device manufacturers and health systems are collaborating more closely to align product design with workflow realities, electronic health record integration, and post-discharge support. This introduction establishes the clinical and operational context for deeper analysis of technological advances, regulatory drivers, and buyer behavior that collectively shape the patient-controlled analgesic pump landscape.

An integrated view of technological, regulatory, and care delivery shifts that are redefining device expectations and procurement criteria in analgesia management

The landscape for patient-controlled analgesic pumps is undergoing rapid transformation as converging forces in technology, policy, and care delivery redefine what clinicians and patients expect from analgesia systems. Advances in connectivity and embedded intelligence have moved devices beyond isolated instruments into components of broader digital care ecosystems, enabling real-time telemetry, dose auditing, and remote alerts that support tighter clinical oversight. At the same time, the rise of opioid stewardship initiatives and heightened scrutiny on safety have accelerated adoption of features that limit bolus frequency, implement mandatory alarms, and support compliance with institutional protocols.

Concurrent shifts in care delivery patterns, particularly the expansion of home-based infusion and shorter inpatient stays, have elevated demand for compact, user-friendly pumps that require minimal technical oversight. Manufacturers are responding by simplifying interfaces, improving battery life, and designing disposables that reduce reprocessing burdens. Interoperability expectations are also reshaping procurement criteria; buyers increasingly demand devices that integrate seamlessly with electronic medical records and supply chain systems. Finally, regulatory emphasis on cybersecurity, data integrity, and post-market surveillance is compelling manufacturers to invest in secure architectures and enhanced post-sale support, which in turn affects product roadmaps and sales strategies.

How the 2025 tariff regime reshaped sourcing, procurement strategies, and manufacturing choices for analgesic pump supply chains across the United States

The cumulative effects of the United States tariffs implemented in 2025 have introduced new dynamics across procurement, manufacturing, and supply chain management for device producers and health systems. Tariffs on imported components and finished devices have sharpened attention on the total landed cost of pumps and consumables, prompting many manufacturers and distributors to re-evaluate sourcing strategies. In response, organizations have accelerated efforts to diversify suppliers, nearshore critical manufacturing elements, and renegotiate long-term supplier contracts to mitigate single-source exposure.

Hospitals and other purchasers have reacted by revisiting contract terms and increasing scrutiny of supplier value propositions to offset elevated acquisition costs. Some providers have intensified focus on standardization across device fleets to reduce inventory complexity and to consolidate purchasing power during renegotiation cycles. Moreover, the tariffs have spurred a renewed interest in domestic manufacturing incentives and public-private partnerships that can insulate essential medical device supply lines from geopolitical and trade disruptions. These developments have also influenced product design priorities: manufacturers are evaluating component substitution, modular architectures, and simplified bill-of-materials to reduce tariff sensitivity while maintaining safety and usability standards.

In-depth segmentation analysis connecting product design, clinical indication, user setting, administration route, and evolving technology requirements for targeted strategies

Segment-level dynamics reveal distinct performance drivers and customer expectations across product, application, end user, route of administration, and technology dimensions. Based on product type, the market is organized into disposable elastomeric devices and volumetric infusion devices, with each pathway addressing different clinical and operational needs; disposable elastomeric options offer simplicity and single-use convenience for certain ambulatory and home care workflows, while volumetric infusion devices offer programmable precision favored in complex inpatient settings. In clinical applications, devices are deployed across cancer-related pain, labor and delivery, and postoperative analgesia, each area demanding tailored dosing profiles, monitoring practices, and patient education approaches that influence device selection and care protocols.

The end-user perspective further differentiates requirements: ambulatory surgical centers prioritize rapid turnover and compact solutions, home care settings require portability, clear instructions, and reliable disposables, and hospitals demand full-featured devices with advanced alarm and monitoring capabilities. Routes of administration-epidural, intravenous, regional block, and subcutaneous-introduce clinical constraints and safety considerations that inform dosing algorithms and accessory needs. From a technology standpoint, the landscape spans elastomeric devices, smart pumps, and traditional pumps; smart pumps, which are increasingly in demand, are further analyzed across EMR-integrated configurations and units offering wireless connectivity, enabling closed-loop documentation, remote updates, and analytics-driven medication safety programs. Together these segmentation layers shape product roadmaps, clinical training investments, and aftermarket service models.

Comparative regional analysis highlighting regulatory frameworks, care delivery models, and manufacturing dynamics shaping device adoption worldwide

Regional dynamics are shaped by regulatory environments, reimbursement structures, care delivery models, and industrial capabilities that collectively influence how devices are adopted and supported. The Americas display a high emphasis on regulatory compliance, interoperability with electronic records, and increasing penetration of home infusion models; reimbursement policies and consolidated health systems are important determinants of procurement priorities, while manufacturing hubs and distribution networks in the region provide avenues for nearshoring component production.

Europe, Middle East & Africa present a varied mosaic in which stringent regional regulatory frameworks, diverse payer mechanisms, and heterogeneous clinical pathways create both opportunities and complexities for market entry and device scaling. In parts of the region, centralized procurement and national health programs favor standardization, while other markets are driven by private hospital systems seeking advanced connectivity and analytics capabilities. Asia-Pacific demonstrates a broad spectrum from advanced tertiary centers in urban markets adopting smart pump solutions with EMR integration to rapidly expanding homecare infrastructures in emerging markets; local manufacturing capability, differing regulatory timelines, and the availability of trained clinical personnel influence adoption patterns and service models across the region.

Strategic competitive overview revealing how product breadth, services, and software-led differentiation determine leadership in analgesic pump commercialization

Competitive dynamics across the patient-controlled analgesic pump landscape are defined by technological differentiation, service offerings, and partnerships across the clinical ecosystem. Market participants that emphasize integration with clinical workflows, robust post-sale support, and data interoperability are often viewed favorably by large health systems seeking to reduce clinician burden and improve medication safety metrics. Meanwhile, manufacturers that offer a range of product formats-from low-complexity disposables to feature-rich programmable pumps-are positioned to serve diverse purchasing channels including hospitals, ambulatory centers, and home care providers.

Strategic activity increasingly focuses on software and analytics layers as a source of differentiation, with companies investing in dose decision support, remote monitoring dashboards, and data services that translate device telemetry into actionable clinical insights. Service and training capabilities remain critical, particularly for home infusion deployments where device simplicity and caregiver education determine outcomes. Competitive pressure also encourages partnerships with electronic health record vendors, contract manufacturers, and logistics providers to secure integrated solutions that reduce implementation friction and lifecycle costs. These shifts underscore the importance of a holistic approach-product performance alone is no longer sufficient; broad-based support models and data-enabled value propositions are pivotal to commercial success.

Concrete, practicable recommendations for manufacturers, health systems, and payers to accelerate adoption, reduce risk, and extract clinical value from devices

Industry leaders should pursue a set of coordinated actions that align product development, commercial strategy, and operational resilience with evolving clinical needs. Manufacturers ought to prioritize interoperability as a core design principle, ensuring that devices support EMR integration and wireless connectivity to facilitate closed-loop documentation and remote monitoring. Strengthening service models is equally important: investing in comprehensive training, rapid-response technical support, and robust warranty and consumable supply programs will lower adoption barriers for hospitals and homecare providers.

Supply chain resilience must be addressed through supplier diversification, strategic nearshoring of critical components, and modular product architectures that allow component substitution without compromising safety. From a commercial perspective, companies should explore outcome-based contracting and evidence-generation partnerships with clinical centers to validate real-world benefits and support procurement discussions. Providers and payers, for their part, can standardize device fleets where clinically appropriate to simplify training and inventory management while piloting smart pump programs linked to analytics to measure safety and cost outcomes. Across stakeholders, a clear focus on cybersecurity, regulatory alignment, and user-centered design will accelerate adoption and protect both patients and institutional investments.

Robust multi-method research approach combining primary clinical interviews, regulatory review, product assessments, and supply chain mapping to validate insights

The research underpinning this analysis combined multiple evidence streams to ensure rigor and practical relevance. Primary inputs included structured interviews with clinicians across acute and ambulatory care settings, biomedical engineering professionals, supply chain leaders, and caregivers experienced in home infusion to capture frontline perspectives on device usability, safety concerns, and procurement drivers. Secondary research incorporated regulatory filings, clinical guidelines, peer-reviewed literature on analgesia delivery, and analysis of public policy documents to contextualize the regulatory environment and standards affecting device design.

Supplementary methods involved mapping supplier networks and manufacturing footprints, reviewing product feature sets through technical specifications and marketing materials, and assessing interoperability capabilities via integration statements and standards adherence. Findings were triangulated across data sources to validate thematic conclusions and identify gaps for further inquiry. Limitations of the approach chiefly relate to the evolving nature of device firmware updates, regional reimbursement variability, and the pace of post-market evidence generation, which require periodic refreshes to maintain the currency of recommendations.

Synthesized conclusions emphasizing the necessity of tailored solutions, interoperability, and cross-stakeholder collaboration to realize device value

Patient-controlled analgesic pumps occupy a pivotal role at the intersection of clinical efficacy, patient empowerment, and operational efficiency. The confluence of technology advances, regulatory focus, and shifting care settings has expanded the capabilities expected from these devices while elevating the importance of interoperability, service models, and supply chain resilience. Segmentation nuances-from product formats and clinical applications to administration routes and end-user environments-underscore that one-size-fits-all solutions are increasingly insufficient; tailored strategies that address the distinct needs of ambulatory surgical centers, home care programs, and hospital systems will be essential for sustained adoption.

Looking ahead, stakeholders that align product design with real-world workflows, invest in data-driven safety and performance features, and strengthen their supply and service ecosystems will be best placed to capture clinical and commercial value. Ongoing collaboration between manufacturers, clinicians, and health systems will remain critical to translate device capabilities into measurable improvements in patient outcomes and operational performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Patient-controlled Analgesic Pumps Market, by Product Type

  • 8.1. Disposable Elastomeric Devices
  • 8.2. Volumetric Infusion Devices

9. Patient-controlled Analgesic Pumps Market, by Technology

  • 9.1. Elastomeric Devices
  • 9.2. Smart Pumps
    • 9.2.1. Emr Integrated
    • 9.2.2. Wireless Connectivity
  • 9.3. Traditional Pumps

10. Patient-controlled Analgesic Pumps Market, by Application

  • 10.1. Cancer Related Pain
  • 10.2. Labor And Delivery
  • 10.3. Postoperative Analgesia

11. Patient-controlled Analgesic Pumps Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Home Care Settings
  • 11.3. Hospitals

12. Patient-controlled Analgesic Pumps Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Patient-controlled Analgesic Pumps Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Patient-controlled Analgesic Pumps Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Patient-controlled Analgesic Pumps Market

16. China Patient-controlled Analgesic Pumps Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Ace Medical
  • 17.7. Avanos Medical, Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Braun Melsungen AG
  • 17.10. Eitan Medical
  • 17.11. Flowonix Medical
  • 17.12. Fresenius Kabi
  • 17.13. Halyard Health
  • 17.14. ICU Medical, Inc.
  • 17.15. IntraPump Infusion Systems
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Medtronic plc
  • 17.18. Mindray Medical International Limited
  • 17.19. Moog Inc.
  • 17.20. Nipro Corporation
  • 17.21. Promecon Medizintechnik GmbH
  • 17.22. Smiths Medical
  • 17.23. Stryker Corporation
  • 17.24. Teleflex Incorporated
  • 17.25. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY DISPOSABLE ELASTOMERIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY DISPOSABLE ELASTOMERIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY DISPOSABLE ELASTOMERIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY VOLUMETRIC INFUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY VOLUMETRIC INFUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY VOLUMETRIC INFUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY ELASTOMERIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY ELASTOMERIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY ELASTOMERIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY EMR INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY EMR INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY EMR INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TRADITIONAL PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TRADITIONAL PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TRADITIONAL PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY CANCER RELATED PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY CANCER RELATED PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY CANCER RELATED PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY LABOR AND DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY LABOR AND DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY LABOR AND DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY POSTOPERATIVE ANALGESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY POSTOPERATIVE ANALGESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY POSTOPERATIVE ANALGESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 106. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GCC PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 124. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. G7 PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 130. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NATO PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA PATIENT-CONTROLLED ANALGESIC PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)